Candriam Equities L Biotechnology, I-H - Capitalisation
WKN A3DUGN | ISIN LU2478813442 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2314628996 | JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR | +34,45 % | +20,27 % | 1,56 |
|
| 2 | LU1991432631 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK | +36,56 % | +23,41 % | 1,44 |
|
| 3 | LU2053354044 | JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - GBP (hedged) | +32,43 % | +20,91 % | 1,42 |
|
| 4 | LU1120766032 | Candriam Equities L Biotechnology, I - Capitalisation | +34,03 % | +22,36 % | 1,40 |
|
| 5 | LU2053353822 | JPMorgan Funds - Thematics - Genetic Therapies A (acc) - GBP (hedged) | +31,68 % | +20,91 % | 1,38 |
|
| 116 | CH0113817123 | Bellevue Biotech DT CHF | +15,56 % | +20,51 % | 0,63 |
|
| 117 | LU1176840327 | Protea Fund - Sectoral Biotech Opportunities Fund PF USD | +16,14 % | +22,02 % | 0,61 |
|
| 118 | LU3110815787 | CPR Invest - Biodiversity - IF1 EURH1 - Acc | +8,97 % | +11,69 % | 0,53 |
|
| 119 | LU3110815944 | CPR Invest - Biodiversity - IF2 EURH1 - Acc | +8,75 % | +11,69 % | 0,52 |
|
| 120 | LU1711916616 | Protea Fund - Sectoral Biotech Opportunities Fund IF H CHF | +11,52 % | +21,92 % | 0,40 |
|